G9137 Onc diagnosis nhl relapse/refractor
Also known as: relapsed refractory NHL, NHL relapse, refractory lymphoma
Oncology diagnosis for non-Hodgkin lymphoma with relapse or refractory disease.
In Plain Language
lymphoma that came back; lymphoma resistant to treatment
Clinical Context
Documentation of non-Hodgkin lymphoma patients with disease relapse after initial therapy or refractory disease, requiring salvage therapy.
RVU Information
CPT G9137 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9137?
CPT G9137 (Onc diagnosis nhl relapse/refractor) is a G Codes code. Oncology diagnosis for non-Hodgkin lymphoma with relapse or refractory disease.
Who uses CPT code G9137?
CPT G9137 is used by Hematologic Oncology, Medical Oncology, Palliative Care. Documentation of non-Hodgkin lymphoma patients with disease relapse after initial therapy or refractory disease, requiring salvage therapy.
When is CPT G9137 used?
Documentation of non-Hodgkin lymphoma patients with disease relapse after initial therapy or refractory disease, requiring salvage therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.